nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—BLK—Kawasaki disease	0.686	1	CbGaD
Bosutinib—Vandetanib—BLK—Kawasaki disease	0.00397	0.653	CrCbGaD
Bosutinib—Vandetanib—VEGFA—Kawasaki disease	0.00211	0.347	CrCbGaD
Bosutinib—SRMS—gall bladder—Kawasaki disease	0.00186	0.0134	CbGeAlD
Bosutinib—STK26—gall bladder—Kawasaki disease	0.00175	0.0126	CbGeAlD
Bosutinib—BMPR2—artery—Kawasaki disease	0.00172	0.0124	CbGeAlD
Bosutinib—IKBKE—heart—Kawasaki disease	0.00159	0.0115	CbGeAlD
Bosutinib—PKMYT1—neck—Kawasaki disease	0.00151	0.0109	CbGeAlD
Bosutinib—CLK3—cardiac ventricle—Kawasaki disease	0.00149	0.0107	CbGeAlD
Bosutinib—EIF2AK1—cardiac ventricle—Kawasaki disease	0.00144	0.0103	CbGeAlD
Bosutinib—CLK3—myocardium—Kawasaki disease	0.0014	0.0101	CbGeAlD
Bosutinib—VRK2—cardiac ventricle—Kawasaki disease	0.00139	0.01	CbGeAlD
Bosutinib—TNIK—cardiac ventricle—Kawasaki disease	0.00136	0.00982	CbGeAlD
Bosutinib—EIF2AK1—myocardium—Kawasaki disease	0.00135	0.00972	CbGeAlD
Bosutinib—CDK2—neck—Kawasaki disease	0.00134	0.00967	CbGeAlD
Bosutinib—VRK2—myocardium—Kawasaki disease	0.00131	0.00942	CbGeAlD
Bosutinib—TNIK—myocardium—Kawasaki disease	0.00128	0.00924	CbGeAlD
Bosutinib—DMPK—cardiac ventricle—Kawasaki disease	0.00128	0.00924	CbGeAlD
Bosutinib—WEE1—cardiac ventricle—Kawasaki disease	0.00128	0.00924	CbGeAlD
Bosutinib—WEE1—myocardium—Kawasaki disease	0.00121	0.00869	CbGeAlD
Bosutinib—DMPK—myocardium—Kawasaki disease	0.00121	0.00869	CbGeAlD
Bosutinib—PLK2—cardiac ventricle—Kawasaki disease	0.00119	0.00857	CbGeAlD
Bosutinib—PTK2—endothelium—Kawasaki disease	0.00116	0.00832	CbGeAlD
Bosutinib—PLK2—myocardium—Kawasaki disease	0.00112	0.00807	CbGeAlD
Bosutinib—SIK3—myocardium—Kawasaki disease	0.00111	0.00801	CbGeAlD
Bosutinib—SRC—artery—Kawasaki disease	0.00106	0.00762	CbGeAlD
Bosutinib—TLK1—heart—Kawasaki disease	0.00105	0.00758	CbGeAlD
Bosutinib—EPHB4—endothelium—Kawasaki disease	0.00105	0.00757	CbGeAlD
Bosutinib—STK33—heart—Kawasaki disease	0.00103	0.00738	CbGeAlD
Bosutinib—FER—myocardium—Kawasaki disease	0.00101	0.00729	CbGeAlD
Bosutinib—CLK3—heart—Kawasaki disease	0.000975	0.00702	CbGeAlD
Bosutinib—BMX—heart—Kawasaki disease	0.000975	0.00702	CbGeAlD
Bosutinib—DSTYK—heart—Kawasaki disease	0.000975	0.00702	CbGeAlD
Bosutinib—BMPR2—cardiac ventricle—Kawasaki disease	0.000965	0.00694	CbGeAlD
Bosutinib—BMX—skin of body—Kawasaki disease	0.000955	0.00687	CbGeAlD
Bosutinib—PHKG1—heart—Kawasaki disease	0.000953	0.00686	CbGeAlD
Bosutinib—CASK—heart—Kawasaki disease	0.000953	0.00686	CbGeAlD
Bosutinib—EIF2AK1—heart—Kawasaki disease	0.000943	0.00678	CbGeAlD
Bosutinib—MAP4K4—cardiac ventricle—Kawasaki disease	0.000928	0.00668	CbGeAlD
Bosutinib—BCR—cardiac ventricle—Kawasaki disease	0.000922	0.00664	CbGeAlD
Bosutinib—FES—heart—Kawasaki disease	0.000914	0.00658	CbGeAlD
Bosutinib—VRK2—heart—Kawasaki disease	0.000914	0.00658	CbGeAlD
Bosutinib—STK35—cardiac ventricle—Kawasaki disease	0.000897	0.00645	CbGeAlD
Bosutinib—TNIK—heart—Kawasaki disease	0.000896	0.00645	CbGeAlD
Bosutinib—SRC—endothelium—Kawasaki disease	0.000894	0.00644	CbGeAlD
Bosutinib—MAP2K1—neck—Kawasaki disease	0.000891	0.00641	CbGeAlD
Bosutinib—CSK—cardiac ventricle—Kawasaki disease	0.000891	0.00641	CbGeAlD
Bosutinib—CDK2—heart—Kawasaki disease	0.000888	0.00639	CbGeAlD
Bosutinib—CSNK1A1—cardiac ventricle—Kawasaki disease	0.000885	0.00637	CbGeAlD
Bosutinib—STK26—heart—Kawasaki disease	0.000879	0.00633	CbGeAlD
Bosutinib—CLK1—cardiac ventricle—Kawasaki disease	0.000879	0.00633	CbGeAlD
Bosutinib—CSNK1A1—neck—Kawasaki disease	0.000879	0.00633	CbGeAlD
Bosutinib—CLK1—neck—Kawasaki disease	0.000874	0.00629	CbGeAlD
Bosutinib—MAP4K4—myocardium—Kawasaki disease	0.000873	0.00629	CbGeAlD
Bosutinib—CDK2—skin of body—Kawasaki disease	0.000869	0.00626	CbGeAlD
Bosutinib—BCR—myocardium—Kawasaki disease	0.000867	0.00624	CbGeAlD
Bosutinib—BMP2K—neck—Kawasaki disease	0.000858	0.00617	CbGeAlD
Bosutinib—STK35—myocardium—Kawasaki disease	0.000843	0.00607	CbGeAlD
Bosutinib—DMPK—heart—Kawasaki disease	0.000842	0.00606	CbGeAlD
Bosutinib—WEE1—heart—Kawasaki disease	0.000842	0.00606	CbGeAlD
Bosutinib—CSK—myocardium—Kawasaki disease	0.000838	0.00603	CbGeAlD
Bosutinib—CSNK1A1—myocardium—Kawasaki disease	0.000832	0.00599	CbGeAlD
Bosutinib—HCK—myocardium—Kawasaki disease	0.000827	0.00595	CbGeAlD
Bosutinib—CLK1—myocardium—Kawasaki disease	0.000827	0.00595	CbGeAlD
Bosutinib—Hepatotoxicity—Acetylsalicylic acid—Kawasaki disease	0.000825	0.12	CcSEcCtD
Bosutinib—CSNK1E—cardiac ventricle—Kawasaki disease	0.00082	0.0059	CbGeAlD
Bosutinib—SIK1—cardiac ventricle—Kawasaki disease	0.000807	0.00581	CbGeAlD
Bosutinib—STK25—heart—Kawasaki disease	0.000804	0.00579	CbGeAlD
Bosutinib—EPHA3—heart—Kawasaki disease	0.000799	0.00575	CbGeAlD
Bosutinib—MAP2K2—cardiac ventricle—Kawasaki disease	0.000789	0.00568	CbGeAlD
Bosutinib—ULK3—cardiac ventricle—Kawasaki disease	0.000789	0.00568	CbGeAlD
Bosutinib—PLK2—heart—Kawasaki disease	0.000782	0.00563	CbGeAlD
Bosutinib—SIK3—heart—Kawasaki disease	0.000777	0.00559	CbGeAlD
Bosutinib—MAP3K7—cardiac ventricle—Kawasaki disease	0.000776	0.00559	CbGeAlD
Bosutinib—TBK1—cardiac ventricle—Kawasaki disease	0.000768	0.00553	CbGeAlD
Bosutinib—PLK2—skin of body—Kawasaki disease	0.000766	0.00551	CbGeAlD
Bosutinib—PTK2—neck—Kawasaki disease	0.000763	0.00549	CbGeAlD
Bosutinib—TBK1—neck—Kawasaki disease	0.000763	0.00549	CbGeAlD
Bosutinib—SIK1—myocardium—Kawasaki disease	0.000759	0.00547	CbGeAlD
Bosutinib—IRAK1—cardiac ventricle—Kawasaki disease	0.000753	0.00542	CbGeAlD
Bosutinib—EPHA4—myocardium—Kawasaki disease	0.000752	0.00541	CbGeAlD
Bosutinib—STK4—heart—Kawasaki disease	0.000748	0.00538	CbGeAlD
Bosutinib—MAP2K2—myocardium—Kawasaki disease	0.000743	0.00535	CbGeAlD
Bosutinib—ULK3—myocardium—Kawasaki disease	0.000743	0.00535	CbGeAlD
Bosutinib—CAMK1D—heart—Kawasaki disease	0.000739	0.00532	CbGeAlD
Bosutinib—RPS6KB1—cardiac ventricle—Kawasaki disease	0.000738	0.00532	CbGeAlD
Bosutinib—RPS6KB1—neck—Kawasaki disease	0.000734	0.00528	CbGeAlD
Bosutinib—AXL—cardiac ventricle—Kawasaki disease	0.000731	0.00526	CbGeAlD
Bosutinib—STK24—heart—Kawasaki disease	0.00073	0.00526	CbGeAlD
Bosutinib—MAP3K7—myocardium—Kawasaki disease	0.00073	0.00526	CbGeAlD
Bosutinib—PTK2—myocardium—Kawasaki disease	0.000722	0.0052	CbGeAlD
Bosutinib—TBK1—myocardium—Kawasaki disease	0.000722	0.0052	CbGeAlD
Bosutinib—Chest discomfort—Acetylsalicylic acid—Kawasaki disease	0.00072	0.105	CcSEcCtD
Bosutinib—STK24—skin of body—Kawasaki disease	0.000715	0.00515	CbGeAlD
Bosutinib—IRAK1—myocardium—Kawasaki disease	0.000708	0.0051	CbGeAlD
Bosutinib—FER—heart—Kawasaki disease	0.000707	0.00509	CbGeAlD
Bosutinib—SLK—cardiac ventricle—Kawasaki disease	0.000704	0.00506	CbGeAlD
Bosutinib—EPHB4—cardiac ventricle—Kawasaki disease	0.000699	0.00503	CbGeAlD
Bosutinib—RPS6KB1—myocardium—Kawasaki disease	0.000695	0.005	CbGeAlD
Bosutinib—MAP4K1—heart—Kawasaki disease	0.000692	0.00498	CbGeAlD
Bosutinib—TYRO3—skin of body—Kawasaki disease	0.000692	0.00498	CbGeAlD
Bosutinib—AXL—myocardium—Kawasaki disease	0.000688	0.00495	CbGeAlD
Bosutinib—FYN—cardiac ventricle—Kawasaki disease	0.000684	0.00492	CbGeAlD
Bosutinib—TNK2—heart—Kawasaki disease	0.000679	0.00489	CbGeAlD
Bosutinib—MAP4K2—heart—Kawasaki disease	0.00067	0.00482	CbGeAlD
Bosutinib—MAP3K3—cardiac ventricle—Kawasaki disease	0.000669	0.00481	CbGeAlD
Bosutinib—SLK—myocardium—Kawasaki disease	0.000662	0.00476	CbGeAlD
Bosutinib—STK3—heart—Kawasaki disease	0.000661	0.00475	CbGeAlD
Bosutinib—ERBB4—heart—Kawasaki disease	0.000661	0.00475	CbGeAlD
Bosutinib—EPHB4—myocardium—Kawasaki disease	0.000657	0.00473	CbGeAlD
Bosutinib—ROCK1—heart—Kawasaki disease	0.000652	0.00469	CbGeAlD
Bosutinib—Respiratory failure—Acetylsalicylic acid—Kawasaki disease	0.000649	0.0944	CcSEcCtD
Bosutinib—FYN—myocardium—Kawasaki disease	0.000644	0.00463	CbGeAlD
Bosutinib—BMPR2—heart—Kawasaki disease	0.000633	0.00456	CbGeAlD
Bosutinib—MAP3K3—myocardium—Kawasaki disease	0.000629	0.00453	CbGeAlD
Bosutinib—STK36—heart—Kawasaki disease	0.000628	0.00452	CbGeAlD
Bosutinib—EPHB3—heart—Kawasaki disease	0.000628	0.00452	CbGeAlD
Bosutinib—MERTK—heart—Kawasaki disease	0.000621	0.00447	CbGeAlD
Bosutinib—BMPR2—skin of body—Kawasaki disease	0.00062	0.00446	CbGeAlD
Bosutinib—PDGFRB—gall bladder—Kawasaki disease	0.000618	0.00445	CbGeAlD
Bosutinib—YES1—cardiac ventricle—Kawasaki disease	0.000617	0.00444	CbGeAlD
Bosutinib—MAP4K4—heart—Kawasaki disease	0.00061	0.00439	CbGeAlD
Bosutinib—TAOK3—cardiac ventricle—Kawasaki disease	0.00061	0.00439	CbGeAlD
Bosutinib—BCR—heart—Kawasaki disease	0.000605	0.00436	CbGeAlD
Bosutinib—MAP3K12—heart—Kawasaki disease	0.000601	0.00433	CbGeAlD
Bosutinib—MAP2K1—heart—Kawasaki disease	0.000589	0.00424	CbGeAlD
Bosutinib—STK35—heart—Kawasaki disease	0.000589	0.00424	CbGeAlD
Bosutinib—CSK—heart—Kawasaki disease	0.000585	0.00421	CbGeAlD
Bosutinib—CSNK1A1—heart—Kawasaki disease	0.000581	0.00418	CbGeAlD
Bosutinib—YES1—myocardium—Kawasaki disease	0.000581	0.00418	CbGeAlD
Bosutinib—HCK—heart—Kawasaki disease	0.000577	0.00416	CbGeAlD
Bosutinib—CLK1—heart—Kawasaki disease	0.000577	0.00416	CbGeAlD
Bosutinib—MAP2K1—skin of body—Kawasaki disease	0.000577	0.00415	CbGeAlD
Bosutinib—STK35—skin of body—Kawasaki disease	0.000577	0.00415	CbGeAlD
Bosutinib—ABL2—heart—Kawasaki disease	0.000574	0.00413	CbGeAlD
Bosutinib—TAOK3—myocardium—Kawasaki disease	0.000573	0.00413	CbGeAlD
Bosutinib—CSK—skin of body—Kawasaki disease	0.000573	0.00412	CbGeAlD
Bosutinib—CSNK1A1—skin of body—Kawasaki disease	0.000569	0.0041	CbGeAlD
Bosutinib—CAMK2G—heart—Kawasaki disease	0.000567	0.00408	CbGeAlD
Bosutinib—BMP2K—heart—Kawasaki disease	0.000567	0.00408	CbGeAlD
Bosutinib—LRRK2—heart—Kawasaki disease	0.000562	0.00404	CbGeAlD
Bosutinib—EGFR—heart—Kawasaki disease	0.00056	0.00403	CbGeAlD
Bosutinib—PTK2B—heart—Kawasaki disease	0.000547	0.00394	CbGeAlD
Bosutinib—CSNK1E—heart—Kawasaki disease	0.000538	0.00388	CbGeAlD
Bosutinib—SIK1—heart—Kawasaki disease	0.00053	0.00382	CbGeAlD
Bosutinib—IRAK4—heart—Kawasaki disease	0.00053	0.00382	CbGeAlD
Bosutinib—CSNK1E—skin of body—Kawasaki disease	0.000527	0.0038	CbGeAlD
Bosutinib—EPHA4—heart—Kawasaki disease	0.000525	0.00378	CbGeAlD
Bosutinib—ERBB3—heart—Kawasaki disease	0.00052	0.00374	CbGeAlD
Bosutinib—SIK1—skin of body—Kawasaki disease	0.000519	0.00374	CbGeAlD
Bosutinib—MAP2K2—heart—Kawasaki disease	0.000518	0.00373	CbGeAlD
Bosutinib—ULK3—heart—Kawasaki disease	0.000518	0.00373	CbGeAlD
Bosutinib—MAP3K2—heart—Kawasaki disease	0.000515	0.0037	CbGeAlD
Bosutinib—MAP2K5—myocardium—Kawasaki disease	0.000514	0.0037	CbGeAlD
Bosutinib—MAP3K7—heart—Kawasaki disease	0.00051	0.00367	CbGeAlD
Bosutinib—ERBB3—skin of body—Kawasaki disease	0.000509	0.00366	CbGeAlD
Bosutinib—MAP2K2—skin of body—Kawasaki disease	0.000508	0.00365	CbGeAlD
Bosutinib—PTK2—heart—Kawasaki disease	0.000504	0.00363	CbGeAlD
Bosutinib—TBK1—heart—Kawasaki disease	0.000504	0.00363	CbGeAlD
Bosutinib—IRAK1—heart—Kawasaki disease	0.000494	0.00356	CbGeAlD
Bosutinib—PTK2—skin of body—Kawasaki disease	0.000494	0.00355	CbGeAlD
Bosutinib—Renal impairment—Acetylsalicylic acid—Kawasaki disease	0.000486	0.0707	CcSEcCtD
Bosutinib—RPS6KB1—heart—Kawasaki disease	0.000485	0.00349	CbGeAlD
Bosutinib—FGR—heart—Kawasaki disease	0.000482	0.00347	CbGeAlD
Bosutinib—LCK—heart—Kawasaki disease	0.000482	0.00347	CbGeAlD
Bosutinib—AXL—heart—Kawasaki disease	0.00048	0.00345	CbGeAlD
Bosutinib—PDGFRB—cardiac ventricle—Kawasaki disease	0.000473	0.0034	CbGeAlD
Bosutinib—AXL—skin of body—Kawasaki disease	0.00047	0.00338	CbGeAlD
Bosutinib—PDGFRB—neck—Kawasaki disease	0.00047	0.00338	CbGeAlD
Bosutinib—Gastrointestinal haemorrhage—Acetylsalicylic acid—Kawasaki disease	0.000463	0.0673	CcSEcCtD
Bosutinib—SLK—heart—Kawasaki disease	0.000462	0.00333	CbGeAlD
Bosutinib—EPHB4—heart—Kawasaki disease	0.000459	0.0033	CbGeAlD
Bosutinib—EPHA2—heart—Kawasaki disease	0.00045	0.00324	CbGeAlD
Bosutinib—FYN—heart—Kawasaki disease	0.000449	0.00323	CbGeAlD
Bosutinib—PDGFRB—myocardium—Kawasaki disease	0.000445	0.0032	CbGeAlD
Bosutinib—FYN—skin of body—Kawasaki disease	0.00044	0.00317	CbGeAlD
Bosutinib—MAP3K3—heart—Kawasaki disease	0.000439	0.00316	CbGeAlD
Bosutinib—MAP4K5—heart—Kawasaki disease	0.000439	0.00316	CbGeAlD
Bosutinib—MAP3K3—skin of body—Kawasaki disease	0.00043	0.00309	CbGeAlD
Bosutinib—ABL1—cardiac ventricle—Kawasaki disease	0.000422	0.00303	CbGeAlD
Bosutinib—YES1—heart—Kawasaki disease	0.000405	0.00292	CbGeAlD
Bosutinib—STK10—heart—Kawasaki disease	0.000402	0.00289	CbGeAlD
Bosutinib—TAOK3—heart—Kawasaki disease	0.0004	0.00288	CbGeAlD
Bosutinib—Influenza—Acetylsalicylic acid—Kawasaki disease	0.0004	0.0581	CcSEcCtD
Bosutinib—ABL1—myocardium—Kawasaki disease	0.000397	0.00285	CbGeAlD
Bosutinib—SRC—heart—Kawasaki disease	0.00039	0.00281	CbGeAlD
Bosutinib—SRC—skin of body—Kawasaki disease	0.000382	0.00275	CbGeAlD
Bosutinib—MAP2K5—heart—Kawasaki disease	0.000359	0.00258	CbGeAlD
Bosutinib—CSF1R—heart—Kawasaki disease	0.00035	0.00252	CbGeAlD
Bosutinib—CSF1R—skin of body—Kawasaki disease	0.000343	0.00247	CbGeAlD
Bosutinib—PDGFRB—heart—Kawasaki disease	0.000311	0.00224	CbGeAlD
Bosutinib—PDGFRB—skin of body—Kawasaki disease	0.000304	0.00219	CbGeAlD
Bosutinib—Tinnitus—Acetylsalicylic acid—Kawasaki disease	0.000298	0.0434	CcSEcCtD
Bosutinib—ABL1—heart—Kawasaki disease	0.000277	0.00199	CbGeAlD
Bosutinib—ABL1—skin of body—Kawasaki disease	0.000271	0.00195	CbGeAlD
Bosutinib—Anaemia—Acetylsalicylic acid—Kawasaki disease	0.000258	0.0374	CcSEcCtD
Bosutinib—Leukopenia—Acetylsalicylic acid—Kawasaki disease	0.000249	0.0363	CcSEcCtD
Bosutinib—Chest pain—Acetylsalicylic acid—Kawasaki disease	0.000237	0.0345	CcSEcCtD
Bosutinib—Arthralgia—Acetylsalicylic acid—Kawasaki disease	0.000237	0.0345	CcSEcCtD
Bosutinib—Anaphylactic shock—Acetylsalicylic acid—Kawasaki disease	0.000227	0.0331	CcSEcCtD
Bosutinib—Thrombocytopenia—Acetylsalicylic acid—Kawasaki disease	0.000223	0.0324	CcSEcCtD
Bosutinib—Dyspnoea—Acetylsalicylic acid—Kawasaki disease	0.000203	0.0295	CcSEcCtD
Bosutinib—Feeling abnormal—Acetylsalicylic acid—Kawasaki disease	0.000187	0.0272	CcSEcCtD
Bosutinib—Urticaria—Acetylsalicylic acid—Kawasaki disease	0.000181	0.0263	CcSEcCtD
Bosutinib—Pruritus—Acetylsalicylic acid—Kawasaki disease	0.000161	0.0234	CcSEcCtD
Bosutinib—Diarrhoea—Acetylsalicylic acid—Kawasaki disease	0.000156	0.0226	CcSEcCtD
Bosutinib—Dizziness—Acetylsalicylic acid—Kawasaki disease	0.00015	0.0219	CcSEcCtD
Bosutinib—Vomiting—Acetylsalicylic acid—Kawasaki disease	0.000145	0.021	CcSEcCtD
Bosutinib—Rash—Acetylsalicylic acid—Kawasaki disease	0.000143	0.0208	CcSEcCtD
Bosutinib—Dermatitis—Acetylsalicylic acid—Kawasaki disease	0.000143	0.0208	CcSEcCtD
Bosutinib—Nausea—Acetylsalicylic acid—Kawasaki disease	0.000135	0.0196	CcSEcCtD
Bosutinib—ABCB1—heart—Kawasaki disease	8.61e-05	0.000619	CbGeAlD
Bosutinib—HCK—Immune System—CRP—Kawasaki disease	2.26e-05	0.00014	CbGpPWpGaD
Bosutinib—FYN—Immune System—BLK—Kawasaki disease	2.26e-05	0.00014	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—BLK—Kawasaki disease	2.25e-05	0.000139	CbGpPWpGaD
Bosutinib—HCK—Disease—CCR5—Kawasaki disease	2.25e-05	0.000139	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CRP—Kawasaki disease	2.21e-05	0.000137	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—MMP9—Kawasaki disease	2.19e-05	0.000135	CbGpPWpGaD
Bosutinib—ERBB3—Innate Immune System—CD4—Kawasaki disease	2.18e-05	0.000135	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CCR5—Kawasaki disease	2.16e-05	0.000134	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CRP—Kawasaki disease	2.16e-05	0.000133	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CRP—Kawasaki disease	2.13e-05	0.000132	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CCR5—Kawasaki disease	2.12e-05	0.000131	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CCR5—Kawasaki disease	2.12e-05	0.000131	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CCR5—Kawasaki disease	2.12e-05	0.000131	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CRP—Kawasaki disease	2.11e-05	0.00013	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CRP—Kawasaki disease	2.1e-05	0.00013	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CRP—Kawasaki disease	2.1e-05	0.00013	CbGpPWpGaD
Bosutinib—SYK—Immune System—CD4—Kawasaki disease	2.1e-05	0.00013	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—CD4—Kawasaki disease	2.09e-05	0.000129	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CRP—Kawasaki disease	2.08e-05	0.000128	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—VEGFA—Kawasaki disease	2.08e-05	0.000128	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CRP—Kawasaki disease	2.07e-05	0.000128	CbGpPWpGaD
Bosutinib—MAP2K2—Axon guidance—MMP9—Kawasaki disease	2.06e-05	0.000127	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—CD4—Kawasaki disease	2.06e-05	0.000127	CbGpPWpGaD
Bosutinib—FGR—Hemostasis—VEGFA—Kawasaki disease	2.06e-05	0.000127	CbGpPWpGaD
Bosutinib—BLK—Immune System—CRP—Kawasaki disease	2.05e-05	0.000127	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CCR5—Kawasaki disease	2.05e-05	0.000127	CbGpPWpGaD
Bosutinib—FGR—Immune System—CRP—Kawasaki disease	2.04e-05	0.000126	CbGpPWpGaD
Bosutinib—EGFR—Immune System—FCGR2A—Kawasaki disease	2.01e-05	0.000124	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD40—Kawasaki disease	2e-05	0.000123	CbGpPWpGaD
Bosutinib—CSK—Immune System—CD4—Kawasaki disease	1.99e-05	0.000123	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—MMP9—Kawasaki disease	1.97e-05	0.000122	CbGpPWpGaD
Bosutinib—LCK—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	1.97e-05	0.000122	CbGpPWpGaD
Bosutinib—SRC—Focal Adhesion—VEGFA—Kawasaki disease	1.97e-05	0.000122	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—VEGFA—Kawasaki disease	1.97e-05	0.000122	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—MMP9—Kawasaki disease	1.96e-05	0.000121	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	1.96e-05	0.000121	CbGpPWpGaD
Bosutinib—EGFR—Immune System—BLK—Kawasaki disease	1.95e-05	0.000121	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD40—Kawasaki disease	1.95e-05	0.00012	CbGpPWpGaD
Bosutinib—LCK—Immune System—FCGR2A—Kawasaki disease	1.94e-05	0.00012	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—MMP9—Kawasaki disease	1.94e-05	0.00012	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—CD4—Kawasaki disease	1.94e-05	0.00012	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—MMP9—Kawasaki disease	1.93e-05	0.000119	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—CD4—Kawasaki disease	1.91e-05	0.000118	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—MMP9—Kawasaki disease	1.91e-05	0.000118	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD40—Kawasaki disease	1.91e-05	0.000118	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—CD4—Kawasaki disease	1.9e-05	0.000118	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—CD4—Kawasaki disease	1.9e-05	0.000118	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD40—Kawasaki disease	1.9e-05	0.000117	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—MMP9—Kawasaki disease	1.89e-05	0.000117	CbGpPWpGaD
Bosutinib—LCK—Immune System—BLK—Kawasaki disease	1.88e-05	0.000116	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD40—Kawasaki disease	1.88e-05	0.000116	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CRP—Kawasaki disease	1.88e-05	0.000116	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD40—Kawasaki disease	1.87e-05	0.000115	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CCR5—Kawasaki disease	1.87e-05	0.000115	CbGpPWpGaD
Bosutinib—MAP2K2—Axon guidance—VEGFA—Kawasaki disease	1.85e-05	0.000114	CbGpPWpGaD
Bosutinib—CSK—Disease—CD4—Kawasaki disease	1.84e-05	0.000114	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—CD4—Kawasaki disease	1.84e-05	0.000113	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—MMP9—Kawasaki disease	1.84e-05	0.000113	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—CD4—Kawasaki disease	1.82e-05	0.000112	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CRP—Kawasaki disease	1.8e-05	0.000111	CbGpPWpGaD
Bosutinib—TBK1—Immune System—CD4—Kawasaki disease	1.79e-05	0.00011	CbGpPWpGaD
Bosutinib—LYN—Axon guidance—VEGFA—Kawasaki disease	1.77e-05	0.000109	CbGpPWpGaD
Bosutinib—ABL1—Axon guidance—VEGFA—Kawasaki disease	1.76e-05	0.000109	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—CD4—Kawasaki disease	1.75e-05	0.000108	CbGpPWpGaD
Bosutinib—SRC—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	1.74e-05	0.000108	CbGpPWpGaD
Bosutinib—FYN—Axon guidance—VEGFA—Kawasaki disease	1.74e-05	0.000108	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—MMP9—Kawasaki disease	1.74e-05	0.000107	CbGpPWpGaD
Bosutinib—MAP2K1—Axon guidance—VEGFA—Kawasaki disease	1.73e-05	0.000107	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CRP—Kawasaki disease	1.73e-05	0.000107	CbGpPWpGaD
Bosutinib—SRC—Immune System—FCGR2A—Kawasaki disease	1.72e-05	0.000106	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—VEGFA—Kawasaki disease	1.72e-05	0.000106	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CCR5—Kawasaki disease	1.72e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—CD4—Kawasaki disease	1.71e-05	0.000106	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—CD4—Kawasaki disease	1.71e-05	0.000106	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—VEGFA—Kawasaki disease	1.69e-05	0.000105	CbGpPWpGaD
Bosutinib—PTK2—Hemostasis—VEGFA—Kawasaki disease	1.69e-05	0.000104	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—MMP9—Kawasaki disease	1.68e-05	0.000104	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CRP—Kawasaki disease	1.67e-05	0.000103	CbGpPWpGaD
Bosutinib—SRC—Immune System—BLK—Kawasaki disease	1.67e-05	0.000103	CbGpPWpGaD
Bosutinib—BTK—Immune System—CD4—Kawasaki disease	1.67e-05	0.000103	CbGpPWpGaD
Bosutinib—YES1—Hemostasis—VEGFA—Kawasaki disease	1.66e-05	0.000103	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—MMP9—Kawasaki disease	1.66e-05	0.000103	CbGpPWpGaD
Bosutinib—YES1—Immune System—CRP—Kawasaki disease	1.65e-05	0.000102	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—VEGFA—Kawasaki disease	1.65e-05	0.000102	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—CD4—Kawasaki disease	1.64e-05	0.000101	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD40—Kawasaki disease	1.62e-05	0.0001	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—CD4—Kawasaki disease	1.59e-05	9.84e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—MMP9—Kawasaki disease	1.59e-05	9.83e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD40—Kawasaki disease	1.57e-05	9.67e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CRP—Kawasaki disease	1.57e-05	9.67e-05	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—VEGFA—Kawasaki disease	1.56e-05	9.65e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—CD4—Kawasaki disease	1.54e-05	9.5e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CRP—Kawasaki disease	1.53e-05	9.47e-05	CbGpPWpGaD
Bosutinib—HCK—Immune System—CD4—Kawasaki disease	1.53e-05	9.44e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—CCR5—Kawasaki disease	1.52e-05	9.36e-05	CbGpPWpGaD
Bosutinib—EGFR—Axon guidance—VEGFA—Kawasaki disease	1.51e-05	9.3e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—CD4—Kawasaki disease	1.49e-05	9.22e-05	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—VEGFA—Kawasaki disease	1.49e-05	9.21e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CCR5—Kawasaki disease	1.48e-05	9.16e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CRP—Kawasaki disease	1.47e-05	9.1e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—MMP9—Kawasaki disease	1.47e-05	9.09e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CCR5—Kawasaki disease	1.46e-05	9.03e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ITPKC—Kawasaki disease	1.46e-05	9.01e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—CD4—Kawasaki disease	1.46e-05	9e-05	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD4—Kawasaki disease	1.44e-05	8.9e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—MMP9—Kawasaki disease	1.43e-05	8.84e-05	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—VEGFA—Kawasaki disease	1.43e-05	8.83e-05	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—CD4—Kawasaki disease	1.43e-05	8.81e-05	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—CD4—Kawasaki disease	1.42e-05	8.77e-05	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD4—Kawasaki disease	1.42e-05	8.77e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—CCR5—Kawasaki disease	1.42e-05	8.76e-05	CbGpPWpGaD
Bosutinib—HCK—Disease—CD4—Kawasaki disease	1.41e-05	8.72e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CCR5—Kawasaki disease	1.41e-05	8.69e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—MMP9—Kawasaki disease	1.41e-05	8.69e-05	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—CD4—Kawasaki disease	1.4e-05	8.68e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—MMP9—Kawasaki disease	1.4e-05	8.65e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD4—Kawasaki disease	1.4e-05	8.64e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—CD4—Kawasaki disease	1.4e-05	8.63e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—MMP9—Kawasaki disease	1.39e-05	8.59e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD40—Kawasaki disease	1.39e-05	8.56e-05	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD4—Kawasaki disease	1.39e-05	8.56e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—MMP9—Kawasaki disease	1.39e-05	8.55e-05	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD4—Kawasaki disease	1.38e-05	8.53e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—MMP9—Kawasaki disease	1.38e-05	8.51e-05	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD4—Kawasaki disease	1.37e-05	8.46e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CCR5—Kawasaki disease	1.36e-05	8.38e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CCR5—Kawasaki disease	1.36e-05	8.38e-05	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD4—Kawasaki disease	1.35e-05	8.33e-05	CbGpPWpGaD
Bosutinib—ERBB4—Disease—CD4—Kawasaki disease	1.33e-05	8.21e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—VEGFA—Kawasaki disease	1.32e-05	8.17e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CCR5—Kawasaki disease	1.31e-05	8.07e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CRP—Kawasaki disease	1.29e-05	7.95e-05	CbGpPWpGaD
Bosutinib—SRC—Axon guidance—VEGFA—Kawasaki disease	1.28e-05	7.93e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CCR5—Kawasaki disease	1.28e-05	7.9e-05	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD4—Kawasaki disease	1.27e-05	7.84e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—VEGFA—Kawasaki disease	1.26e-05	7.8e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—VEGFA—Kawasaki disease	1.26e-05	7.77e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CRP—Kawasaki disease	1.26e-05	7.76e-05	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—VEGFA—Kawasaki disease	1.25e-05	7.72e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CCR5—Kawasaki disease	1.25e-05	7.71e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—VEGFA—Kawasaki disease	1.24e-05	7.68e-05	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—VEGFA—Kawasaki disease	1.24e-05	7.65e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—VEGFA—Kawasaki disease	1.24e-05	7.64e-05	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—VEGFA—Kawasaki disease	1.23e-05	7.62e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CCR5—Kawasaki disease	1.23e-05	7.61e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CRP—Kawasaki disease	1.23e-05	7.6e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CRP—Kawasaki disease	1.22e-05	7.56e-05	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—VEGFA—Kawasaki disease	1.22e-05	7.54e-05	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—CD4—Kawasaki disease	1.21e-05	7.5e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CRP—Kawasaki disease	1.21e-05	7.48e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CRP—Kawasaki disease	1.2e-05	7.44e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CCR5—Kawasaki disease	1.2e-05	7.43e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—MMP9—Kawasaki disease	1.2e-05	7.39e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CCR5—Kawasaki disease	1.2e-05	7.39e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—MMP9—Kawasaki disease	1.18e-05	7.31e-05	CbGpPWpGaD
Bosutinib—ERBB3—Disease—CD4—Kawasaki disease	1.17e-05	7.24e-05	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—CD4—Kawasaki disease	1.17e-05	7.22e-05	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD4—Kawasaki disease	1.17e-05	7.2e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CCR5—Kawasaki disease	1.16e-05	7.19e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—MMP9—Kawasaki disease	1.16e-05	7.17e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—MMP9—Kawasaki disease	1.16e-05	7.17e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	1.16e-05	7.16e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CCR5—Kawasaki disease	1.15e-05	7.09e-05	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD4—Kawasaki disease	1.13e-05	6.98e-05	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD4—Kawasaki disease	1.12e-05	6.94e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—MMP9—Kawasaki disease	1.12e-05	6.93e-05	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD4—Kawasaki disease	1.11e-05	6.88e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CCR5—Kawasaki disease	1.09e-05	6.72e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—VEGFA—Kawasaki disease	1.07e-05	6.64e-05	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—VEGFA—Kawasaki disease	1.06e-05	6.56e-05	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD4—Kawasaki disease	1.06e-05	6.53e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CRP—Kawasaki disease	1.05e-05	6.46e-05	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—VEGFA—Kawasaki disease	1.04e-05	6.44e-05	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—VEGFA—Kawasaki disease	1.04e-05	6.44e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CCR5—Kawasaki disease	1.04e-05	6.42e-05	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—CD4—Kawasaki disease	1.04e-05	6.39e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CCR5—Kawasaki disease	1.02e-05	6.33e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—MMP9—Kawasaki disease	1.02e-05	6.31e-05	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—VEGFA—Kawasaki disease	1.02e-05	6.27e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CRP—Kawasaki disease	1.01e-05	6.23e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—VEGFA—Kawasaki disease	1.01e-05	6.22e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CCR5—Kawasaki disease	1e-05	6.19e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD4—Kawasaki disease	9.95e-06	6.15e-05	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD4—Kawasaki disease	9.94e-06	6.14e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—MMP9—Kawasaki disease	9.38e-06	5.79e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—VEGFA—Kawasaki disease	9.17e-06	5.66e-05	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—VEGFA—Kawasaki disease	8.99e-06	5.55e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCR5—Kawasaki disease	8.96e-06	5.53e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CRP—Kawasaki disease	8.93e-06	5.51e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CCR5—Kawasaki disease	8.87e-06	5.48e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCR5—Kawasaki disease	8.74e-06	5.4e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD4—Kawasaki disease	8.7e-06	5.37e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCR5—Kawasaki disease	8.56e-06	5.28e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD4—Kawasaki disease	8.49e-06	5.24e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—VEGFA—Kawasaki disease	8.43e-06	5.2e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCR5—Kawasaki disease	8.42e-06	5.2e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCR5—Kawasaki disease	8.38e-06	5.17e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD4—Kawasaki disease	8.31e-06	5.13e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD4—Kawasaki disease	8.27e-06	5.11e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD4—Kawasaki disease	8.18e-06	5.05e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD4—Kawasaki disease	8.14e-06	5.03e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—MMP9—Kawasaki disease	8.11e-06	5.01e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—CD4—Kawasaki disease	8.03e-06	4.96e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—MMP9—Kawasaki disease	7.99e-06	4.94e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CD4—Kawasaki disease	7.84e-06	4.84e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—MMP9—Kawasaki disease	7.7e-06	4.75e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—CD4—Kawasaki disease	7.55e-06	4.67e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CD4—Kawasaki disease	7.51e-06	4.64e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—MMP9—Kawasaki disease	7.42e-06	4.58e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—MMP9—Kawasaki disease	7.42e-06	4.58e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—VEGFA—Kawasaki disease	7.28e-06	4.5e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR5—Kawasaki disease	7.28e-06	4.49e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—VEGFA—Kawasaki disease	7.18e-06	4.43e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—MMP9—Kawasaki disease	7.15e-06	4.42e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD4—Kawasaki disease	7.07e-06	4.37e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR5—Kawasaki disease	7.01e-06	4.33e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—VEGFA—Kawasaki disease	6.91e-06	4.27e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—Kawasaki disease	6.81e-06	4.21e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—VEGFA—Kawasaki disease	6.66e-06	4.11e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VEGFA—Kawasaki disease	6.66e-06	4.11e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—Kawasaki disease	6.53e-06	4.03e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VEGFA—Kawasaki disease	6.42e-06	3.96e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—Kawasaki disease	6.36e-06	3.93e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—Kawasaki disease	6.29e-06	3.88e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—Kawasaki disease	6.28e-06	3.88e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—Kawasaki disease	6.21e-06	3.83e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—Kawasaki disease	6.03e-06	3.72e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—Kawasaki disease	5.95e-06	3.68e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—Kawasaki disease	5.71e-06	3.53e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—Kawasaki disease	5.64e-06	3.48e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—Kawasaki disease	5.6e-06	3.46e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—Kawasaki disease	5.57e-06	3.44e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—Kawasaki disease	5.34e-06	3.3e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—Kawasaki disease	5.03e-06	3.11e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—Kawasaki disease	4.9e-06	3.02e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—Kawasaki disease	4.78e-06	2.95e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—Kawasaki disease	4.68e-06	2.89e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—Kawasaki disease	4.61e-06	2.85e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—Kawasaki disease	4.58e-06	2.83e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—Kawasaki disease	4.4e-06	2.72e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—Kawasaki disease	4.29e-06	2.65e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—Kawasaki disease	4.2e-06	2.59e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—Kawasaki disease	4.14e-06	2.55e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—Kawasaki disease	4.11e-06	2.54e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—Kawasaki disease	3.98e-06	2.46e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—Kawasaki disease	3.84e-06	2.37e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—Kawasaki disease	3.57e-06	2.21e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—Kawasaki disease	3.44e-06	2.13e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—Kawasaki disease	3.4e-06	2.1e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—Kawasaki disease	3.05e-06	1.88e-05	CbGpPWpGaD
